CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Grant or award | +52,774 | 68,286.39 | ||
| 2021-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −12,538 | $12.69 | $159K | 55,748.39 |
| 2021-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −52,774 | $12.69 | $670K | 2,974.39 |
| 2021-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −12,538 | 12,538 | ||
| 2021-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Grant or award · Restricted Share Units | +37,884 | 37,884 | ||
| 2021-02-09 | Schultz Kare President and CEO | Option exercise | +26,867 | 509,661 | ||
| 2021-02-09 | Schultz Kare President and CEO | Grant or award | +226,173 | 735,834 | ||
| 2021-02-09 | Schultz Kare President and CEO | Option exercise · Restricted Share Units | −26,867 | 26,867 | ||
| 2021-02-09 | Sabag Mark See "Remarks" below | Option exercise | +15,523 | 40,273 | ||
| 2021-02-09 | Sabag Mark See "Remarks" below | Grant or award | +65,339 | 105,612 | ||
| 2021-02-09 | Sabag Mark See "Remarks" below | Option exercise · Restricted Share Units | −15,523 | 15,523 | ||
| 2021-02-09 | Sabag Mark See "Remarks" below | Grant or award · Restricted Share Units | +37,884 | 37,884 | ||
| 2021-02-09 | O'Grady Brendan P. EVP, North America Commercial | Option exercise | +16,120 | 30,988.49 | ||
| 2021-02-09 | O'Grady Brendan P. EVP, North America Commercial | Grant or award | +67,852 | 98,840.49 | ||
| 2021-02-09 | O'Grady Brendan P. EVP, North America Commercial | Sale | −3,974 | $12.69 | $50K | 94,866.49 |
| 2021-02-09 | O'Grady Brendan P. EVP, North America Commercial | Sale | −16,720 | $12.69 | $212K | 78,146.49 |
| 2021-02-09 | O'Grady Brendan P. EVP, North America Commercial | Option exercise · Restricted Share Units | −16,120 | 16,121 | ||
| 2021-02-09 | Nazzi Gianfranco EVP, International Markets | Option exercise | +11,941 | 31,785.36 | ||
| 2021-02-09 | Nazzi Gianfranco EVP, International Markets | Grant or award | +50,260 | 82,045.36 | ||
| 2021-02-09 | Nazzi Gianfranco EVP, International Markets | Sale | −4,155 | $12.72 | $53K | 77,890.36 |
Page 51 of 76 · 1,517 trades